Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S6 pseudogene 12 (RPS6P12) is a processed pseudogene of the ribosomal protein S6 gene located in the human genome[1][4][6]. Pseudogenes such as RPS6P12 are genomic DNA sequences similar to normal genes but typically non-functional: they *do not encode a functional protein* due to mutations, truncations, or loss of regulatory elements[1][2]. While most pseudogenes were historically considered "junk DNA", recent research shows that some can play *regulatory roles* at the RNA level, including acting as microRNA decoys or being transcribed into regulatory RNAs, which may modulate the expression of their cognate functional genes[2]. However, for RPS6P12 specifically, there is no evidence of protein-coding function, drug interactions, or established use as a therapeutic target, biomarker, or disease gene[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S6 pseudogene 12 (RPS6P12).